IMPase in Treatment-resistant Depression

Clinical trial NCT05117710 · UNKNOWN

Trial details

NCT number: NCT05117710
Sponsor: University of Oxford
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder, Treatment-Resistant

Start date: 2021-04-22
Primary completion: 2024-05-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.